By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Ignyta 

11095 Flintkote Avenue
Suite D
San Diego  California  92121  U.S.A.
Phone: Fax:


SEARCH JOBS


Industry
Biotechnology






Company News
Ignyta (RXDX) Release: Late-Breaking Oral Plenary Presentation Of A Novel Entrectinib Combination Regimen At The 2016 EORTC-NCI-AACR Annual Meeting 12/2/2016 11:01:32 AM
Ignyta (RXDX) Announces Compelling Phase I/Ib Clinical Data On RXDX-105, Its VEGFR-Sparing RET Inhibitor, At The 2016 EORTC-Ignyta (RXDX)-NCI Annual Meeting 12/1/2016 10:50:12 AM
Ignyta (RXDX) To Debut Preclinical Data On RXDX-106 At The 2016 EORTC-NCI-AACR Annual Meeting 11/29/2016 10:58:32 AM
Ignyta (RXDX) Announces EAP Designation And CE Marking For Its Trailblaze Pharos Clinical Trial Assay 11/15/2016 10:17:14 AM
Ignyta (RXDX) Announces Six Upcoming Presentations At The 2016 EORTC-NCI-AACR Annual Meeting 11/14/2016 11:44:18 AM
Ignyta (RXDX) Announces Third Quarter 2016 Company Highlights And Financial Results 11/8/2016 10:48:09 AM
Ignyta (RXDX) To Present At The Ladenburg Thalmann 2016 Healthcare Conference 9/26/2016 12:21:36 PM
EORTC And Ignyta (RXDX) Expand Collaborative Agreement For Precision Medicine 9/19/2016 10:09:21 AM
Ignyta (RXDX) To Present At 2016 Silicon Valley Bank Healthcare Capital And Connections Summit 9/15/2016 11:26:19 AM
Ignyta (RXDX) Announces Approval Of An Investigational Device Exemption (IDE) For The Companion Diagnostic Assay To The STARTRK-2 Trial 8/31/2016 10:51:10 AM
12345678910...
//-->